These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976 [TBL] [Abstract][Full Text] [Related]
3. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. MacAllister RJ; Rambausek MH; Vallance P; Williams D; Hoffmann KH; Ritz E Nephrol Dial Transplant; 1996 Dec; 11(12):2449-52. PubMed ID: 9017621 [TBL] [Abstract][Full Text] [Related]
4. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Busch M; Fleck C; Wolf G; Stein G Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between serum asymmetric dimethylarginine and blood pressure in patients with chronic renal failure]. Zhang WR; Tao LJ; Chen BM Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):133-4. PubMed ID: 12575339 [TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Fleck C; Schweitzer F; Karge E; Busch M; Stein G Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. Anderstam B; Katzarski K; Bergström J J Am Soc Nephrol; 1997 Sep; 8(9):1437-42. PubMed ID: 9294836 [TBL] [Abstract][Full Text] [Related]
8. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952 [TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. Kielstein JT; Böger RH; Bode-Böger SM; Schäffer J; Barbey M; Koch KM; Frölich JC J Am Soc Nephrol; 1999 Mar; 10(3):594-600. PubMed ID: 10073610 [TBL] [Abstract][Full Text] [Related]
10. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease. Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918 [TBL] [Abstract][Full Text] [Related]
11. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients. Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913 [TBL] [Abstract][Full Text] [Related]
12. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients. Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709 [TBL] [Abstract][Full Text] [Related]
13. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels. Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743 [TBL] [Abstract][Full Text] [Related]
14. The differences of asymmetric dimethylarginine removal by different dialysis treatments. Zhang DL; Liu J; Liu S; Zhang Y; Liu WH Ren Fail; 2010; 32(8):935-40. PubMed ID: 20722560 [TBL] [Abstract][Full Text] [Related]
15. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. Kielstein JT; Böger RH; Bode-Böger SM; Frölich JC; Haller H; Ritz E; Fliser D J Am Soc Nephrol; 2002 Jan; 13(1):170-176. PubMed ID: 11752034 [TBL] [Abstract][Full Text] [Related]
16. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Wang S; Vicente FB; Miller A; Brooks ER; Price HE; Smith FA Clin Chem Lab Med; 2007; 45(10):1305-12. PubMed ID: 17663630 [TBL] [Abstract][Full Text] [Related]
17. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198 [TBL] [Abstract][Full Text] [Related]
18. Dimethylarginine levels and nutritional status in hemodialysis patients. Cupisti A; Saba A; D'Alessandro C; Meola M; Panicucci E; Panichi V; Raffaelli A; Barsotti G J Nephrol; 2009; 22(5):623-9. PubMed ID: 19809995 [TBL] [Abstract][Full Text] [Related]
19. Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography. Hov GG; Sagen E; Bigonah A; Asberg A Scand J Clin Lab Invest; 2007; 67(8):868-76. PubMed ID: 17852822 [TBL] [Abstract][Full Text] [Related]
20. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension. Mangoni AA; Hewitson CL; Woodman RJ; Whiting MJ; McAteer-Carr B; Barbara JA Am J Hypertens; 2008 Aug; 21(8):955-9. PubMed ID: 18551101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]